Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An International Oncology Study Group (IOSG) Phase II protocol

Francis J. Giles*, Nicholas R. Wickham, Bernardo L. Rapoport, George Somlo, Stephen W. Lim, Jianqin Shan, Anne M. Lynott

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An International Oncology Study Group (IOSG) Phase II protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences